amoxicillin + clavulanate + benzylpenicillin

Amoxicillin + clavulanate + benzylpenicillin refers to a clinical study context at the Combined Military Hospital in Pakistan evaluating the comparative efficacy of intravenous co-amoxiclav (amoxicillin/clavulanic acid) and benzyl penicillin (Penicillin G) for severe streptococcal tonsillitis in children. Amoxicillin and benzyl penicillin are beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Clavulanic acid is a beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation by beta-lactamase-producing bacteria. This research aimed to establish the safety, efficacy, and cost-effectiveness of these parenteral antibiotic regimens in a pediatric hospital setting.

Other names

co-amoxiclav + benzyl penicillinamoxicillin/clavulanic acid + benzylpenicillinco-amoxiclav + benzyl penicillin-Combined Military Hospital, Pakistan-streptococcal tonsillitis